As seen on Fox Business Read More
Andrew Gostine, MDCritical Care Anesthesiologist,
Northwestern Medicine, Stanford Healthcare
Dianhong Dai, Ph.D.As a full-time scientist at the Wellman Center for Photomedicine, I have been involved in research and published on the use of light to treat infectious diseases. UV Angel has a team of scientists and engineers, in partnership with some very large and successful companies, developing state-of-the-art technologies that are addressing the unmet needs of medicine today. I am pleased to be able to contribute to that as part of the Clinical Advisory Board. I am excited about many of the technologies the team is working on.
Tianhong Dai, Ph.D
Assistant Professor of Dermatology
Massachusetts General Hospital
Dr. Jeffrey A. Gelfand, MDAs an infectious disease specialist, I have been interested in the power of light for the prevention and treatment of diseases for some time. We are constantly challenged by new infectious agents, multidrug-resistant pathogens, and disease transmission. COVID-19 is a stark reminder of how vulnerable we are as a global society and, to be sure, this will not be the last pandemic challenge in our lifetime. I am excited by UV Angel and participating in the Clinical Advisory Board. When I first met the team, I was immediately struck by the fact that they really “get it.” It’s obvious that there are gaps in our approach to infectious disease prevention as well as treatment. The air as a source of contamination is obvious but I have not seen any group or company approach the problem of decontaminating the air we breathe in such objective and science-based technologies that meet the needs not only today but for years to come. The team is made up of stars in the field and I feel fortunate to be part of that team.
Jeffrey Gelfand, MD
Professor of Medicine, Harvard Medical School
Physician, Infectious Disease Unit, Massachusetts General Hospital
Yingying Haung, MD – Ph.D.My education and training in Dermatology led me to the Wellman Center for Photomedicine at Harvard, where my research into the power of light opened a new approach to disease prevention and treatment. UV Angel not only represents the best in technology aimed at the use of light in this setting but also supports clinical and bench research with a team of highly trained and respected clinicians and scientists whose goals align with mine. I am excited to be working with UV Angel and to participate as a member of the Clinical Advisory Board that helps to drive the science, and I look forward to helping them develop new technologies to combat disease.
Yingying Huang, MD, Ph.D
Jacqueline Schultz, RN, MSN CNAAAs a hospital administrator and a nurse, I have lived through all sorts of healthcare crises. COVID-19, however, has really shone a light on the toll a pandemic can take on our healthcare system. Not only are the patients very ill, scared, and often alone, but our nurses, ancillary, and support staff are vulnerable as well. The air has been shown to be a significant source of infection. Break rooms are too often ignored in the cleaning process. As weary staff take a break, pull off their masks, and drink and eat when they can, they are at risk. UV Angel technologies address unmet needs by disinfecting the air as well as surfaces not attended by standard cleaning. Backed by science and supported by an incredible team, the technologies offer unique approaches to disease prevention that will stand the test of time. That is why I am proud to be part of the UV Angel Clinical Advisory Board.
Jacky Schultz, R.N., M.S.N., C.N.A.A.
Formerly, President Suburban Hospital/ Johns Hopkins Medicine
Bob Rothstein, MDI have been fascinated for quite a while with the potential of various wavelengths of light to prevent and treat infectious diseases. While that, on the surface, may not seem to be in the wheelhouse of an Emergency Physician, in fact Emergency Departments often serve as canaries in the coal mines of new diseases. I am honored to be part of a company developing cutting-edge technologies that can benefit our patients and staff. As a hospital administrator, I also saw the immediate potential utility of UV Angel products throughout the hospital and the rest of the healthcare system. The COVID-19 pandemic has challenged us beyond anything we have seen for at least a century, but this will not be the last we see of new, highly contagious, rapidly spreading pathogens. UV Angel offers unique approaches and valuable technologies to our armamentarium to fight these pathogens. I am excited by the current and new products in development by our team and our partners. If you have to fight a war, it’s nice to be well-armed.
Robert Rothstein, MD
Chairman Clinical Advisory Board, UV Angel
Bret LewisCFO
Bret offers over 30 years of executive leadership experience building and growing successful, strategically focused businesses.
Before UV Angel, Bret served as Chief Operating Officer for Cherette Group, a fully integrated property development/real estate company. Bret coordinated all operational aspects for the West Michigan firm, including investment performance, bank relationships, finance, and risk management.
From 2007 to 2013 Bret was Managing Director of Fulton Innovation, a division of Amway Corporation. Offering value-driven strategic direction, Bret’s work was instrumental to the commercialization of eCoupled™, the wireless power technology developed by UV Angel’s, Dave Baarman, and his team of engineers and scientists.
With Fulton Innovation as one of the founding members of the Wireless Power Consortium, Bret served as co-chairman of the steering committee responsible for developing the Qi standard, the globally recognized standard for wireless power.
Entrepreneurially minded, Bret has owned and operated companies around the world in industries ranging from component and advanced manufacturing systems to energy and real estate. He has also held senior-level positions in sales, marketing, operations, and finance with both public and privately held companies.
Bret is a graduate of Carroll University where he majored in Business and Finance. He and his wife, Rebecca, have two sons and make their home in West Michigan.
Dr. Linda Lee, MBA, CICChief Medical Affairs & Science Officer
A sought-after health industry speaker and author, Dr. Lee has spent over 30 years working with organizations, ranging from CH2M Hill to the MD Anderson Cancer Center.
A certified indoor air quality manager and certified in infection control with a focus on the relationship of opportunistic environmental pathogens, Dr. Lee brings more than three decades of experience to her role at UV Angel.
In addition to positions at CH2M Hill, WM Healthcare Solutions, the University of Texas MD Anderson Cancer Center, and Stericycle, Dr. Lee has authored numerous peer-reviewed publications as well as three American Hospital Association-published books.
After earning her Bachelor’s in Environmental Health Science from Indiana State University, Dr. Lee earned a Master’s in Operations Management from the University of Arkansas College of Engineering. She completed a Doctorate of Public Health in Occupational and Environmental Health from the University of Texas Health Science Center and has an MBA with an emphasis in Healthcare Management.
Dr. Lee has been invited to present at SHEA, AIHce, IPAC-Canada, and the C Diff Foundation Conference and is a corresponding Member of ASHRAE Ultraviolet Air & Surface Treatment-T-TAC-TC02.09 & ASHRAE Roster Health Care Facilities-T-TAC-TC09.06.
In her spare time, Dr. Lee enjoys spending time with her three grandchildren and rooting on her Houston Texans.
Dave JerovsekCOO
Dave Jerovsek brings extensive electronic/mechatronic systems knowledge with product-based high-volume manufacturing operations experience to UV Angel that will be a significant value-add to our organization. Dave’s overall business leadership experience and industry intel from various markets such as Automotive, Appliance, and Commercial Vehicle to name a few, will certainly prove to be a positive impact to our team and vision. Most recently with automotive-based GHSP of Grand Haven, MI, Dave has held domestic and global responsibilities ranging from General Manager Electronics Operations, Director of Program Management, Vice President of Operations, and President- North America and Emerging Markets. Dave has greatly impacted all levels of organizations by leading teams through significant cultural and core-competency technology changes, resulting in record growth. In addition to 30+ years of relative industry experience, Dave holds an AS Degree in Electronics Technology, and BBA in Financial Analysis & Business Leadership from Baker College.
Tom ByrneCEO
Tom brings more than three decades of strategic business development and leadership experience to the technology, and health and life sciences industries.
With a focus on defining strategy and driving revenue in emerging markets, Tom has a passion for integrating health needs with cutting-edge product solutions. By working closely with customers, he finds innovative ways to empower teams to develop products that improve outcomes in multiple markets.
Before his role at UV Angel, Tom founded Byrne Advisory Group, where his team provided sales, engineering, and product development expertise to a range of clients.
Tom began his healthcare career as an Account Executive for McKesson General Medical. He then advanced his responsibilities, first as a Regional Sales Manager for Stryker Corporation, then as a Vice President for a closely held medical products company in Grand Rapids, Michigan.
A graduate of Northwood University DeVos School of Business, Tom sits on Advisory Boards for a range of early-stage companies, and actively supports a host of community and educational initiatives. He and his wife, Paula, have three children and live in Grand Haven, Michigan.
Paul ByrneVice President of Product
With experience leading onshore and offshore development teams, Paul is recognized for his ability to understand user needs and integrate them, quickly and effectively, into groundbreaking technologies. He has worked with numerous national and international companies spanning the healthcare, life sciences, retail, and consumer goods industries.
Prior to UV Angel, Paul served as a Senior Digital Strategy Consultant for IBM. In his role, he worked on projects ranging from AI-enhanced healthcare prediction systems to education analytics to large-scale enterprise applications.
He began his career with Cisco Systems in Sales and Product Strategy, where he focused on technologies that would enable greater sales team performance.
Paul is a graduate of the Ross School of Business at the University of Michigan. Based in Washington, DC, he enjoys volunteering, travel, and skiing in his free time.
Ted ColeFounder
Ted has 25 years of experience in leadership roles in Information Technology. This includes founding West Michigan’s first all-Windows based online service which focused on West Michigan’s 450 Churches. This innovative service received a grant from the Pine Rest Foundation in recognition of its public-service value. Ted also served as Director of Information Services & Director of Telecommunications for Holland Home, a large West Michigan Nonprofit that provides a wide array of health services, assisted living, & other services to the elderly.
Dave BaarmanChief Technology & Innovation Officer
A pioneer in electronic design and structured innovation, Dave oversees the platform of the UV Angel ecosystem and intellectual property portfolio.
Previously the Director of Advanced Technologies at Fulton Innovation, a division of Amway Corporation, Dave was the lead inventor of eCoupled™ intelligent wireless power technology.
Recognized around the globe, eCoupled is a foundational technology implemented in the Qi global wireless power standard. In addition to eCoupled, Dave was responsible for the technical supervision and development of several Fulton Innovation technologies.
Dave joined Amway in 1997, where he pioneered the use of intelligent inductive coupling in the eSpring Water Purifier. On the market for eight years, more than 1.5 million devices were sold in 38 countries.
Prior to Amway, Dave founded EBW Electronics, which today is rated 2,338th in the US, boasting 166% growth over the past three years.
Baarman holds over 300 US patents, 560 foreign patents, and has 350 patent applications pending. He is a 2010-2011 Michigan Leadership in Innovation finalist, 2011 Edison Award finalist, 2012 Best in Biz Award winner, 2012 Technology Executive of the Year, and 2012 Product Development/Management Executive of the Year.
